Navigating the Use of Small Molecules to Treat GBMs Through Improved BBB Crossing
- Exploring the advantages of small molecules in GBM treatment including crossing the BBB effectively and reaching tumour cells in the CNS
- Designing small molecules to selectively target specific molecular pathways and genetic alterations driving GBM growth and resistance
- Highlighting the role of small molecules within combination therapies to optimize their use alongside other treatments